Illumina signals beyond the news: 69+ signals from 7 sources
The latest Illumina signal on this page is from Sep 29, 2026 (Patents): "Illumina was granted a patent for substrates supporting sample quantification." The busiest sources: Glassdoor (15+), LinkedIn (15+) and Website changes (15+).
Public (ILMN)Biotechnology Research10,000+ employeesillumina.comLinkedIn
- Signals
- 69+
- Sources
- 7
- Last 90 days
- 57
- Latest
- Sep 29, 2026
Other signals · latest 10
Latest Illumina signals by source
69+ signals for Illumina across 7 sources.
Patents · Patent grant
Illumina was granted a patent for substrates supporting sample quantification.
In September 2026 Illumina patented a plate-based imaging setup for quantifying biological samples in laboratory and genomic analysis workflows.
- Patent title
- Substrates for performing quantification processes and related systems and methods
- Grant date
- Sep 29, 2026
- Inventors
- Bryan Crane
Patents · Patent grant
Illumina was granted a patent for flexible nanopore sequencing circuits
In September 2026 Illumina patented voltage-control electronics for reading DNA through nanopores, used in compact genetic sequencing instruments.
- Patent title
- Circuit design to apply different voltages in a nanopore array
- Grant date
- Sep 29, 2026
- Inventors
- Mohsen Rezaei, Arvin Emadi
Reddit · Customer feedback
A user experiencing periodic 10 bp peaks in RNA-seq data from an Illumina NovaSeq X Plus was informed by a self-identified Illumina employee that this pattern is a known artifact of...
Post: "Weird periodic insert size distribution (~10 bp peaks) in RNA-seq"
- Subreddit
- r/bioinformatics
- Upvotes
- 18
- Comments
- 22
- Sentiment
- Neutral
Reddit · Customer feedback
A UK-based customer reports receiving a significant discount on their £180,000 Illumina NextSeq 2000 purchase, attributing it to their established history with the company and an equipment trade-in.
Post: "Anyone have recent real-world pricing for Element AVITI vs NextSeq 2000?"
- Subreddit
- r/genomics
- Upvotes
- 2
- Comments
- 4
- Sentiment
- Positive
Web traffic · Sustained decline
illumina.com shows sustained decline with 3 consecutive months of decreases, down 24% overall to 635K.
Minimal AI traffic at 0.6% (~3,991 visits). Top: chatgpt.com (72%), gemini.google.com (23%), perplexity.ai (3%), claude.ai (0%).
- Monthly visits
- 634,937
- Month over month
- -20.3%
- 3-month change
- -23.9%
- Global rank
- 60,751
Glassdoor · Growth opportunities
Lack of career growth and slow promotions reported by employees
Multiple reviews indicate limited growth opportunities, with one specifically mentioning slow promotions depending on the organization and another stating the company doesn't seem to value talent.
- Overall rating
- 3.3 of 5
- CEO approval
- 47%
- Reviews read
- 10
- Review window
- Aug 15, 2026 to Sep 2, 2026
Website changes · Product expansion
Illumina expanded the catalog’s cross-selling and bundled-product presentation with additional “Frequently purchased together” and “View all bundles” calls to action.
The diff adds “Frequently purchased together” and “View all bundles” overlays alongside existing product groupings and bundles.
- Page
- /products.html
Web traffic · Traffic snapshot
illumina.com received 797K monthly visits with traffic from 5 countries.
Minimal AI traffic at 0.5% (~3,890 visits). Top: chatgpt.com (77%), gemini.google.com (15%), claude.ai (5%), perplexity.ai (0%).
- Monthly visits
- 796,797
- Month over month
- -4.5%
- 3-month change
- +12.4%
- Global rank
- 51,198
LinkedIn
PUM Szczecin researchers use Illumina 5-base solution for tumor classification and precision medicine.
“We are on the brink of a revolution,” says Tomasz K. Wojdacz. Researchers at PUM in Szczecin Poland are using the Illumina 5-base solution to develop more accurate, standardized approaches to tumor classification. By bringing methylation and genomic sequencing data together, they’re gaining a powerful new lens...
- Likes
- 58
- Comments
- 2
- Tags
- Data Science, Medical Research, Product Launch
- Initiatives
- developing accurate tumor classification approaches, accelerating precision medicine
YouTube
Remake✨ Oltre il Tuo Sorriso - Canzone d'Amore che Illumina il Cuore✨ #webcreator
WEB CREATOR promotes new love song 'Oltre il Tuo Sorriso' across streaming platforms.
- Channel
- WEB CREATOR anonimous artists
- Views
- 1
- Comments
- 0
- Tags
- Music Release, Artist Promotion
Showing 10 of 69+ signals. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Illumina with the Signal API
One POST /v1/companies/enrich call with illumina.com returns Illumina signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{
"domain": "illumina.com",
"signal_types": ["reddit-company","podcast-company","glassdoor-company",
"product-reviews","linkedin-post-company","twitter-company-posts",
"youtube-company","website-intelligence","patents-company",
"federal-contract-award","conference-speaker","hackernews",
"producthunt-launch","seo-traffic"],
"limit": 20
}'Same industry
Other signals at related companies
Questions about Illumina other signals
What signals does Autobound track for Illumina besides news and filings?
What are people saying about Illumina online?
What do employees say about working at Illumina?
Has Illumina been granted patents recently?
Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.
Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.
Data as of .